Inovio Pharmaceuticals Inc (INO)
10.12
-0.25
(-2.41%)
USD |
NASDAQ |
Apr 24, 16:00
10.12
0.00 (0.00%)
After-Hours: 20:00
Inovio Pharmaceuticals Cash from Operations (TTM): -124.37M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -124.37M |
September 30, 2023 | -134.43M |
June 30, 2023 | -172.78M |
March 31, 2023 | -191.00M |
December 31, 2022 | -216.22M |
September 30, 2022 | -217.77M |
June 30, 2022 | -196.79M |
March 31, 2022 | -224.72M |
December 31, 2021 | -215.71M |
September 30, 2021 | -229.03M |
June 30, 2021 | -256.70M |
March 31, 2021 | -205.39M |
December 31, 2020 | -177.98M |
September 30, 2020 | -140.50M |
June 30, 2020 | -94.08M |
March 31, 2020 | -90.85M |
December 31, 2019 | -97.85M |
September 30, 2019 | -101.39M |
June 30, 2019 | -98.33M |
March 31, 2019 | -93.43M |
December 31, 2018 | -73.55M |
September 30, 2018 | -70.22M |
June 30, 2018 | -62.86M |
March 31, 2018 | -60.56M |
December 31, 2017 | -63.21M |
Date | Value |
---|---|
September 30, 2017 | -64.16M |
June 30, 2017 | -65.49M |
March 31, 2017 | -62.04M |
December 31, 2016 | -62.56M |
September 30, 2016 | -54.43M |
June 30, 2016 | -20.36M |
March 31, 2016 | -16.11M |
December 31, 2015 | -12.44M |
September 30, 2015 | -13.74M |
June 30, 2015 | -37.21M |
March 31, 2015 | -36.33M |
December 31, 2014 | -29.82M |
September 30, 2014 | -20.87M |
June 30, 2014 | -18.54M |
March 31, 2014 | -15.81M |
December 31, 2013 | -15.38M |
September 30, 2013 | -21.78M |
June 30, 2013 | -22.11M |
March 31, 2013 | -22.00M |
December 31, 2012 | -22.31M |
September 30, 2012 | -21.32M |
June 30, 2012 | -20.55M |
March 31, 2012 | -19.69M |
December 31, 2011 | -19.76M |
September 30, 2011 | -18.57M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-256.70M
Minimum
Jun 2021
-90.85M
Maximum
Mar 2020
-167.68M
Average
-177.98M
Median
Dec 2020
Cash from Operations (TTM) Benchmarks
Cerus Corp | -43.17M |
Stereotaxis Inc | -9.139M |
Viemed Healthcare Inc | 45.21M |
AIM ImmunoTech Inc | -21.27M |
Protalix BioTherapeutics Inc | -1.318M |